70 results
424B5
ARQT
Arcutis Biotherapeutics Inc
1 Mar 24
Prospectus supplement for primary offering
4:06pm
voting for the election of directors in our restated certificate of incorporation, which means that holders of a majority of the shares of our common stock … is permitted to be set only by a resolution adopted by a majority vote of our entire board of directors. These provisions would prevent a stockholder from
424B5
ARQT
Arcutis Biotherapeutics Inc
28 Feb 24
Prospectus supplement for primary offering
4:21pm
that holders of a majority of the shares of our common stock will be able to elect all of our directors. Our restated certificate of incorporation … of directors constituting our board of directors is permitted to be set only by a resolution adopted by a majority vote of our entire board
424B5
wrig z08q0
8 Feb 24
Prospectus supplement for primary offering
4:31pm
S-3
EX-4.5
sh80cs jhoz
31 Jan 24
Shelf registration
5:22pm
S-3
89bh8qi ok9z3db
31 Jan 24
Shelf registration
5:22pm
SC TO-I
EX-99
1xskqvf5 ytjd9fy6
16 Jan 24
Issuer tender offer statement
6:03am
SC TO-I
EX-99
ty8uvre z9edd6tc
16 Jan 24
Issuer tender offer statement
6:03am
424B5
htpgam2pu9
23 Oct 23
Prospectus supplement for primary offering
4:23pm
424B5
x5img45y4m t0el67if
19 Oct 23
Prospectus supplement for primary offering
4:15pm
8-K
EX-99.1
5d660jvg5 4oub
7 Sep 22
Entry into a Material Definitive Agreement
5:04pm
424B5
mmvez9uapv4to
4 Aug 22
Prospectus supplement for primary offering
6:03am
8-K
EX-99.1
npb3xj90md7p
2 Aug 22
Fda Approves Arcutis’ Zoryve™ (Roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis In Individuals Age 12 and Older
4:01pm